Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
<p>Abstract</p> <p>Background</p> <p>Tumor vasculature frequently fails to supply sufficient levels of oxygen to tumor tissue resulting in radioresistant hypoxic tumors. To improve therapeutic outcome radiotherapy (RT) may be combined with cytotoxic agents.</p> &l...
Main Authors: | Røe Kathrine, Hagtvet Eirik, Olsen Dag R |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | Radiation Oncology |
Online Access: | http://www.ro-journal.com/content/6/1/135 |
Similar Items
-
Radiotherapy and inhibition of the EGF family as treatment strategies for prostate cancer: combining theragnostics with theragates
by: Wolfgang Lilleby, et al.
Published: (2011-06-01) -
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
by: Zhen Yuan, et al.
Published: (2021-01-01) -
Co-Loading of Black Phosphorus Nanoflakes and Doxorubicin in Lysolipid Temperature-Sensitive Liposomes for Combination Therapy in Prostate Cancer
by: Chandrima Das, et al.
Published: (2023-12-01) -
Normoxic Tumour Extracellular Vesicles Modulate the Response of Hypoxic Cancer and Stromal Cells to Doxorubicin In Vitro
by: Laura Patras, et al.
Published: (2020-08-01) -
Synergistic inhibition of melanoma xenografts by Brequinar sodium and Doxorubicin
by: Dorasamy, Mathura Subangari, et al.
Published: (2019)